In POHs March Newsletter Harry Rosen wrote in his Corporate Update that POH was in discussions with parties on OTCs (deal ann 2 days later on JV with Quigley Corp); Animal Health (deal ann on Insulin for Animals with Novartis last week) and Dermatological Drugs.
So I think it fair to say we can expect a deal on Derma drugs soon.
What is a Dermatological Drug? These are drugs to treat skin disorders and diseases. They generally fall into the folling categories:
Acne and Rosacea
Antiaging and Photodamage
Dermatitis and Seborrhea
Fungal Infections
Hair Loss and Hair Removal
Hyperpigmentation/Melasma
Psoriasis
Skin Cancer, and
Other Skin Disorders.
POH has done a substantial amount of research in this area as highlighted by its Phase 1b Clinical Trial in April 2009 on Retinoic Acid. In this trial ,one hour after application of POHs TPM retinoic acid formulation, Phosphagenics delivered, on average, 375% more retinoic acid into the skin than the commercial product, Retin-A. This trial showed that the POH formulation achieved greater efficacy, no erythmea, and elimination of the risk of systemic toxicity due to the targeted, localised delivery of the active into the skin and muscle tissues while avoiding systemic exposure.
So what do we think
KC
- Forums
- ASX - By Stock
- AVE
- pohs next deal: demeratological drugs
pohs next deal: demeratological drugs
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $20.06K | 10.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 32398999 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 46150696 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 32148999 | 0.002 |
18 | 36561741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 46150696 | 25 |
0.004 | 28020712 | 16 |
0.005 | 9325199 | 9 |
0.006 | 19380067 | 10 |
0.007 | 5722471 | 6 |
Last trade - 13.15pm 13/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online